BackHCA Healthcare Overview
HCA Healthcare Inc

HCA Healthcare Target Price

See HCA Healthcare's analyst price targets ($450) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$495.02

Average Target Price

$447.799.5% downside

19 analysts in the last 4 months

High: $579 | Low: $369

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-10-29BarclaysAndrew Mok$40119% downsideOpen
2026-10-28Mizuho Securities$4950% upsideOpen
2026-10-28KeyBancMatthew Gillmor$4901% downsideOpen
2026-10-07RBC Capital$4960.2% upsideOpen
2026-09-22BMO Capital$4950% upsideOpen
2026-07-28Goldman Sachs$4852% downsideOpen
2026-07-27OppenheimerMichael Wiederhorn$4852% downsideOpen
2026-07-27KeyBanc$43512.1% downsideOpen
2026-07-27UBS$57917% upsideOpen
2026-07-27Barclays$38721.8% downsideOpen
2026-07-27Morgan Stanley$38023.2% downsideOpen
2026-07-27Deutsche Bank$4763.8% downsideOpen
2026-07-27Robert W. Baird$39320.6% downsideOpen
2026-07-20Wells FargoStephen Baxter$36925.5% downsideOpen
2026-07-16Barclays$40218.8% downsideOpen
2026-07-15RBC Capital$43512.1% downsideOpen
2026-07-14Jefferies$4509.1% downsideOpen
2026-07-13Wells Fargo$42813.5% downsideOpen
2026-07-08Barclays$42713.7% downsideOpen
2026-07-07Cantor Fitzgerald$5256.1% upsideOpen
2026-07-07Raymond JamesSarah James$5286.7% upsideOpen
2026-06-04Bernstein$41316.6% downsideOpen
2026-06-04Truist Financial$41316.6% downsideOpen
2026-04-27Stephens$5307.1% upsideOpen
2026-04-27Barclays$4960.2% upsideOpen
2026-04-27RBC Capital$5347.9% upsideOpen
2026-04-27KeyBanc$5103% upsideOpen
2026-04-27Wells Fargo$43611.9% downsideOpen
2026-04-27Truist Financial$5358.1% upsideOpen
2026-04-27Oppenheimer$5205% upsideOpen
2026-04-24Jefferies$5256.1% upsideOpen
2026-02-23UBS$63528.3% upsideOpen
2026-02-09Bernstein$5419.3% upsideOpen
2026-02-02Mizuho Securities$5409.1% upsideOpen
2026-01-30Wells Fargo$4812.8% downsideOpen
2026-01-28UBS$59820.8% upsideOpen
2026-01-28KeyBanc$5031.6% upsideOpen
2026-01-28RBC Capital$55512.1% upsideOpen
2026-01-28UBS$58818.8% upsideOpen
2026-01-28BarclaysAndrew Mok$55111.3% upsideOpen
2026-01-28KeyBanc$55011.1% upsideOpen
2026-01-28Oppenheimer$5409.1% upsideOpen
2026-01-22KeyBanc$5001% upsideOpen
2026-01-07Wells FargoStephen Baxter$4528.7% downsideOpen
2026-01-06Bernstein$5031.6% upsideOpen
2025-12-18Mizuho Securities$5205% upsideOpen
2025-10-27Barclays$4940.2% downsideOpen
2025-10-27RBC CapitalBen Hendrix$4822.6% downsideOpen
2025-10-27StephensRaj Kumar$5001% upsideOpen
2025-10-27Truist Financial$4950% upsideOpen

HCA Healthcare (HCA) FAQ

As of the most recent data, HCA shows a target price of $450. Scroll down for historical charts and peer comparison views.

If HCA Healthcare moved to the average analyst target of $450, shares would be roughly 9.5% lower than $495.02. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of HCA Healthcare's earnings trajectory.

Besides this target price page, Stockcircle has HCA Healthcare's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $450) with ownership activity and broader fundamentals.

HCA Healthcare's target price is $450; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.